Moderna, an American pharmaceutical company, announced in an experiment that three doses of the new coronavirus vaccine significantly increased the effect of neutralizing antibodies on the Omicron strain of the mutant virus.
On the 20th, Moderna announced the results of initial experiments conducted in the laboratory on the effects of the new coronavirus vaccine on the Omicron strain.
According to this, the effect of the neutralizing antibody, which weakens the action of the virus, was lower than that of the conventional virus for the Omicron strain in the blood of the person who received the vaccine twice.
However, after receiving the third booster, the effect of the neutralizing antibody increased significantly, and the 50 microgram inoculation used for the third inoculation in Japan and the United States increased by about 37 times, and the first. It is about 83 times that of 100 micrograms, which is the same as the two inoculations.
Moderna continues to develop a vaccine specialized for the Omicron strain, but says that it can be expected to have a sufficient effect on the Omicron strain by inoculating the vaccine currently used three times. I don't think I need the vaccine I got. "